🍽🦠 PubMed Studies Citing Bacteria Shifts for bacillus subtilis (probiotics) - Akkermansia glycaniphila

Citations are updated once a week. Recently added citations may not appear.

2 Citations Found, Full List Requires Login Summary Publisher Link Html Article Download Article Why do I only have some/no links buttons showing?
๐Ÿ““ - Direct Citation   |   ๐Ÿ‘ช - Infer Parent  |   ๐Ÿ‘ถ - Infer Child |   โš—๏ธ - Inferred from bacteria association
For Samples: ๐Ÿ˜ - Shifts in right direction   |   ๐Ÿ˜ข - Shifts in wrong direction
Context Citation
bacillus subtilis (probiotics) - Akkermansia glycaniphila    👶 Enterococcus faecium R0026 combined with Bacillus subtilis R0179 prevent obesity-associated hyperlipidaemia and modulate gut microbiota in C57BL/6 mice.
Journal of microbiology and biotechnology (J Microbiol Biotechnol ) Vol: Issue Pages:
Pub: 2020 Oct 20 Epub: 2020 Oct 20 Authors Huang J , Huang J , Yin T , Lv H , Zhang P , Li H ,
Publication
bacillus subtilis (probiotics) - Akkermansia glycaniphila    👶 Treatment with a spore-based probiotic containing five strains of Bacillus induced changes in the metabolic activity and community composition of the gut microbiota in a SHIMEยฎ model of the human gastrointestinal system.
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 149 Issue Pages: 110676
Pub: 2021 Nov Epub: 2021 Aug 30 Authors Marzorati M , Van den Abbeele P , Bubeck S , Bayne T , Krishnan K , Young A ,
Publication

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 ยงโ€ฏ1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)